Very Good Points. It is a way for the Conglomerates to gain control once again. Scary to the small guy/small business owner if you think about it! What can we do about it to head it off at the pass?
Is Apple's Stock Headed for a Reversal? [View article]
Demand is definitly there. I would love to buy an iPhone but refuse to switch to at&t's network (I am sure there are others like me out there). Where are the iPhones produced? Does Apple have it's own factories? They are going to need to ramp up production!
Apple (AAPL): FQ4 EPS of $1.82 beats by $0.40. Sales of $9.87B vs. $9.2B. Sees FQ1 EPS of $1.70-1.87 vs. consensus of $1.91 on sales of $11.3-11.6B, in line. Sold 3.05M Macs, 10.2M iPods, and 7.4M iPhones during quarter. Gross margin 36.6%. Shares +5.1% AH. (PR) [View news story]
How Should We Improve Seeking Alpha's Comment Rating System? [View instapost]
meant to say on my last comment ............. "I do agree with the other posters, as far as thumbs up, thumbs down ISN'T clear enough on whether something was good bad or indifferent."
How Should We Improve Seeking Alpha's Comment Rating System? [View instapost]
I love the interactability (if that is a word) of the site, that’s what makes SA great (and this site is way better than a standard message board), so don’t take anything away, tweak and add to make things more accurate.
Idea from another site I frequent…
... The comment section on bleacherreport.com isn't much to talk about (see link to article with comments: bleacherreport.com/art...). However, the do a great job with the articles author rankings. You may need to sign up to see how it is structured.
Depending upon how much you contribute you become:
Senior Writer (Top) Columnist Analyst Scribe Contributor Member (Bottom)
The more you contribute to the site, the more say/pull you should have in commenting on an article.
I do agree with the other posters, as far as thumbs up, thumbs down is clear enough on whether something was good bad or indifferent.
Nanoviricides (NNVC.OB) another small bio-tech just put out a press release in relation to Swine Flu:
WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that it is developing FluCide(™), its flagship anti-influenza drug candidate, to work against all influenza types and subtypes. FluCide has been shown to be effective against both common influenza subtype H1N1, as well as two different variants of bird flu subtype H5N1.
Note of apology to our users: Our hosting service had a major outage this morning that took Seeking Alpha down for about five hours. We're back up now, and working hard to get all the articles in our backlog up on the site. [View news story]
A Two-Tier Internet? [View article]
December Update from Seeking Alpha's CEO: Series B Funding Round, Nasdaq.com Partnership [View article]
Usability Problems with Twitter and Facebook [View instapost]
Seeking Alpha Completes Series B Funding Round [View instapost]
New Instablogs Worth Watching [View instapost]
Why Research in Motion Is a Takeover Target [View article]
Why Research in Motion Is a Takeover Target [View article]
Has anyone seen the new Nokia N900 - Let's not forget about NOK. I think they finally got this right.
Check this video of it out gizmodo.com/5401888/th...
Makes the Droid look scared! All they need now is a Carrier for it in the good old USA!
Is Apple's Stock Headed for a Reversal? [View article]
Apple (AAPL): FQ4 EPS of $1.82 beats by $0.40. Sales of $9.87B vs. $9.2B. Sees FQ1 EPS of $1.70-1.87 vs. consensus of $1.91 on sales of $11.3-11.6B, in line. Sold 3.05M Macs, 10.2M iPods, and 7.4M iPhones during quarter. Gross margin 36.6%. Shares +5.1% AH. (PR) [View news story]
How Should We Improve Seeking Alpha's Comment Rating System? [View instapost]
How Should We Improve Seeking Alpha's Comment Rating System? [View instapost]
Idea from another site I frequent…
... The comment section on bleacherreport.com isn't much to talk about (see link to article with comments: bleacherreport.com/art...). However, the do a great job with the articles author rankings. You may need to sign up to see how it is structured.
Depending upon how much you contribute you become:
Senior Writer (Top)
Columnist
Analyst
Scribe
Contributor
Member (Bottom)
The more you contribute to the site, the more say/pull you should have in commenting on an article.
I do agree with the other posters, as far as thumbs up, thumbs down is clear enough on whether something was good bad or indifferent.
Swine Flu: Why You Can Ignore the Hype [View article]
Novavax: Swine Flu Vaccine Maker's Shares Surge [View article]
WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced that it is developing FluCide(™), its flagship anti-influenza drug candidate, to work against all influenza types and subtypes. FluCide has been shown to be effective against both common influenza subtype H1N1, as well as two different variants of bird flu subtype H5N1.
www.businesswire.com/p...
Note of apology to our users: Our hosting service had a major outage this morning that took Seeking Alpha down for about five hours. We're back up now, and working hard to get all the articles in our backlog up on the site. [View news story]
Bonus Backlash Is Upon Us, But a Well Structured Plan Benefits Shareholders [View article]